Contrasting impacts of pretransplant cytoreduction and post‐transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real‐world multicentre evidence
cell dose and donor age) substantially improve outcomes after allo-HSCT for MDS. These findings highlight actionable strategies that may refine transplant decision-making and optimize outcomes in clinical practice.
Authors
- Haizhou Xing
- W. Shi (ORCID: https://orcid.org/0000-0002-8102-9002)
- Ling Qin (ORCID: https://orcid.org/0000-0002-2582-0078)
- Zhilei Bian (ORCID: https://orcid.org/0000-0003-0680-4029)
- Yi Liu (ORCID: https://orcid.org/0000-0003-4370-3227)
- Mengdi Wang (ORCID: https://orcid.org/0000-0002-2101-9507)
- Jing Zhang (ORCID: https://orcid.org/0000-0003-3064-7625)
- Yi Chen (ORCID: https://orcid.org/0000-0002-5180-3490)
- Dingming Wan
- Wenliang Tian
- Xiaotong Zhang
- Zhongxing Jiang
- Huili Xu
- Weijie Cao
- Xuefang Zhou
- Xinsheng Xie
- Na Shen
Institutions
- Union Hospital (HK)
- Pingdingshan University (CN)
- Zhengzhou University (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Zhengzhou Business University (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1111/bjh.70477
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China